Free Trial

Next Century Growth Investors LLC Increases Stock Position in Arteris, Inc. $AIP

Arteris logo with Computer and Technology background

Key Points

  • Next Century Growth Investors LLC increased its stake in Arteris, Inc. by 46.4%, bringing its ownership to 407,721 shares valued at approximately $2.8 million.
  • Several other institutional investors have established new positions in Arteris, with 64.36% of the stock currently held by hedge funds and other institutions.
  • Despite a recent "buy" rating from analysts, Arteris stock has traded down by 0.9%, with a current market cap of $413.71 million and a price target consensus of $15.00.
  • Looking to export and analyze Arteris data? Unlock 5 Weeks of MarketBeat All Access for Just $5. Claim Your Limited-Time Discount.

Next Century Growth Investors LLC increased its position in Arteris, Inc. (NASDAQ:AIP - Free Report) by 46.4% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 407,721 shares of the company's stock after purchasing an additional 129,143 shares during the quarter. Next Century Growth Investors LLC owned 0.98% of Arteris worth $2,817,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also made changes to their positions in the company. Quarry LP purchased a new position in shares of Arteris in the fourth quarter valued at $46,000. CWM LLC raised its holdings in Arteris by 4,810.1% in the first quarter. CWM LLC now owns 10,213 shares of the company's stock valued at $71,000 after acquiring an additional 10,005 shares in the last quarter. Cambridge Investment Research Advisors Inc. acquired a new stake in Arteris in the first quarter valued at $95,000. D. E. Shaw & Co. Inc. acquired a new stake in Arteris in the fourth quarter valued at $110,000. Finally, Price T Rowe Associates Inc. MD acquired a new stake in Arteris in the fourth quarter valued at $117,000. 64.36% of the stock is currently owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other news, major shareholder Bayview Legacy, Llc sold 50,000 shares of Arteris stock in a transaction that occurred on Tuesday, August 5th. The shares were sold at an average price of $13.12, for a total value of $656,000.00. Following the transaction, the insider directly owned 9,839,071 shares of the company's stock, valued at $129,088,611.52. This trade represents a 0.51% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, COO Laurent R. Moll sold 34,400 shares of Arteris stock in a transaction that occurred on Tuesday, August 5th. The stock was sold at an average price of $13.57, for a total transaction of $466,808.00. Following the completion of the transaction, the chief operating officer directly owned 442,071 shares in the company, valued at approximately $5,998,903.47. This trade represents a 7.22% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 456,043 shares of company stock valued at $5,484,028 over the last 90 days. 29.10% of the stock is owned by corporate insiders.

Analyst Ratings Changes

A number of analysts recently weighed in on the stock. Rosenblatt Securities reaffirmed a "buy" rating and issued a $14.00 price objective on shares of Arteris in a report on Wednesday, May 21st. TD Cowen increased their price objective on shares of Arteris from $12.00 to $15.00 and gave the stock a "buy" rating in a report on Wednesday, August 6th. Finally, Wall Street Zen cut shares of Arteris from a "hold" rating to a "sell" rating in a report on Friday, August 22nd. Three equities research analysts have rated the stock with a Buy rating, Based on data from MarketBeat, Arteris has a consensus rating of "Buy" and a consensus price target of $15.00.

Check Out Our Latest Analysis on Arteris

Arteris Trading Down 0.9%

Arteris stock opened at $9.70 on Thursday. The stock has a market cap of $413.71 million, a price-to-earnings ratio of -11.83 and a beta of 1.45. The company's 50-day moving average price is $9.51 and its two-hundred day moving average price is $8.27. Arteris, Inc. has a 52 week low of $5.46 and a 52 week high of $14.29.

Arteris (NASDAQ:AIP - Get Free Report) last posted its quarterly earnings data on Tuesday, August 5th. The company reported ($0.11) earnings per share for the quarter, meeting the consensus estimate of ($0.11). Arteris had a negative net margin of 52.41% and a negative return on equity of 8,546.17%. The company had revenue of $16,502 billion during the quarter, compared to analyst estimates of $16.35 million. Arteris has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. Research analysts expect that Arteris, Inc. will post -0.73 earnings per share for the current fiscal year.

About Arteris

(Free Report)

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.

Recommended Stories

Want to see what other hedge funds are holding AIP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Arteris, Inc. (NASDAQ:AIP - Free Report).

Institutional Ownership by Quarter for Arteris (NASDAQ:AIP)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Arteris Right Now?

Before you consider Arteris, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Arteris wasn't on the list.

While Arteris currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

$15 Billion for Cybersecurity: The Government’s Next Big Push
Tesla’s Future Unleashed: Elon’s Robotics Move Changes Everything
Top Trades: Massive Gains and Costly Mistakes to Avoid

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines